Register / Other
Melatonin
2 authorised claims · NRV not set
What the regulation allows
- “Melatonin melatonin contributes to the alleviation of subjective feelings of jet lag (0.5 mg)”
- “Melatonin melatonin contributes to the reduction of time taken to fall asleep (1 mg)”
Dose condition
0.5 mg for the jet-lag claim; 1 mg for the sleep-onset claim
Reg. 432/2012, Annex: jet lag — at least 0.5 mg per quantified portion, with the statement that 0.5 mg taken close to bedtime on the first day of travel and the following few days is what the evidence used. Sleep onset — exactly 1 mg per quantified portion, with the statement that 1 mg close to bedtime is what the evidence used.
Wording that fails
| Phrase | Why it fails |
|---|---|
| “Melatonin cures insomnia” | Reads as a disease claim, which needs an Article 14 authorisation. |
| “Melatonin is non-hormonal” | Not among the authorised wordings for this substance. |
| “Melatonin is safe for children (no authorised claim, and restricted in several member states)” | Not among the authorised wordings for this substance. |
In a gummy
Melatonin is light-sensitive and slightly bitter. Several member states restrict sale to pharmacies or set maximum doses, so a single EU-wide label is not possible.
Marketing phrases that touch this substance
| Phrase | Verdict | Authorised alternative |
|---|---|---|
| Helps you sleep | Not allowed | contributes to the reduction of time taken to fall asleep |